Bio View's revenue for the
six
months ended in Jun. 2024 was ₪17.04 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2024 was ₪34.34 Mil.
Bio View's Revenue per Share for the
six
months ended in Jun. 2024 was ₪0.12.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was ₪0.24.
Warning Sign:
Bio View Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Bio View was -5.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 10.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 4.00% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 1.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Bio View's highest 3-Year average Revenue per Share Growth Rate was 11.70% per year. The lowest was -10.50% per year. And the median was 1.60% per year.
Bio View Revenue Historical Data
The historical data trend for Bio View's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Bio View's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio View's Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bio View's Revenue distribution charts can be found below:
* The bar in red indicates where Bio View's Revenue falls into.
Bio View Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪34.34 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio View (XTAE:BIOV) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Bio View Revenue Related Terms
Thank you for viewing the detailed overview of Bio View's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Bio View Ltd is an Israel based company engaged in the research, development, manufacture, marketing, and sale of computerized systems for identification of rate cells and test for detection of cancer. It manufactures and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, pathology clinical and research laboratories. Geographically, the group has its business presence in Israel, USA, and other countries, of which majority of the revenue is derived from the USA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTAE:BIOV has been successfully added to your 